Navigation Links
Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma
Date:3/25/2011

New York, March 25, 2011 The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.

Ipilimumab uses a novel approach known as immunotherapy, which exploits the body's own immune system to attack cancer. The therapy, originally known as anti-CTLA-4, was developed in 1996 by James Allison, PhD, Chair of the Sloan-Kettering Institute's Immunology Program at MSKCC. For more than 20 years, Dr. Allison's research has focused on the mechanisms that regulate the immunologic responses of T lymphocytes commonly referred to as T cells with an emphasis on manipulating T cell response in order to develop novel tumor immunotherapy approaches.

Over the years, Memorial Sloan-Kettering researchers were deeply involved in preclinical and clinical studies using ipilimumab, most notably a 2009 phase II multicenter trial led by medical oncologist Jedd Wolchok, MD, PhD. Dr. Wolchok was a participant in the phase III trial, presented in 2010 at the American Society of Clinical Oncology annual meeting, which found a dose-response relationship to the drug in patients with stage III or IV disease. He also led a team in the development of a novel set of tumor-response criteria based on ipilimumab's unique mechanism of action.

Together, recent advances in understanding intracellular signaling pathways and immunotherapies such as ipilimumab to block those pathways have allowed clinicians to offer melanoma patients new treatment options for this disease.

"Ipilimumab is the first drug ever to be shown to produce an improvement in overall survival for patients with metastatic melanoma," according to Dr. Wolchok. "This is a significant achievement in a disease which has been so resistant to standard therapies. It is also a great source of hope for
'/>"/>

Contact: Jeanne DAgostino
dagostij@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
2. A novel in vitro model for light-induced wound healing
3. Novel program translates behavioral and social science research into treatments to reduce obesity
4. Reovirus may be a novel approach to prostate cancer treatment
5. Novel stroke treatment passes safety stage of UCI-led clinical trial
6. Novel medical home program for pediatric patients, families cuts ER visits in half
7. MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010
8. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
9. Novel Method Eyed for Normalizing Blood Sugar
10. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
11. Novel nanoparticles prevent radiation damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... US (PRWEB) May 22, 2013 Award ... , Read the press release here: http://bit.ly/13DkFfk ... DataSite® was named “Information Management Product/Service of the Year” ... in March at The Colony Hotel in Palm Beach, ... virtual data room (VDR) solution that optimizes ...
(Date:5/22/2013)... Utah (PRWEB) May 22, 2013 Registered Dietitian ... an article today on Tatalou.com sharing a recipe for making ... Your Own Healthy Energy Bars ,” takes a recipe modified ... few important twists. , “Every day it gets more and ... our bodies,” said Chevreau. “The size of the nutrition label ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ICE Safety ... Women of Influence Award in recognition for her outstanding ... took place on Thursday, May 2 at The Fairmont, ... humbling for the 5,000 people ICE Safety Solutions certifies ... recognize the four to nine lives saved per year ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... children who die each year awaiting an organ donation ... increasing numbers of children are receiving donor organs. ... donors expanded to include not just patients who,ve experienced ... of death." But it,s unclear how much that ...
(Date:5/22/2013)... URBANA - A University of Illinois researcher says that ... should be to encourage more people to participate in ... , According to Craig Gundersen, SNAP, formerly known as ... net program and with some additional improvements could be ... households. Gundersen is a U of I professor of ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3
... Expected for Western Drug Companies, According to a Report ... Resources, one of the world,s leading research and advisory ... the colorectal cancer drug market in China will ... in 2007 to $290 million in 2012. This growth ...
... Three Grand Prize Winners Will Meet Nick Jonas TARRYTOWN, N.Y., ... Jonas of the Jonas Brothers invite kids and teens with ... Contest" online for a chance to meet Nick in person. ... Care and Nick, who has type 1 diabetes and uses ...
... 13 Adam Kluger Public Relations ( www.adamklugerpr.com ) announced Monday that AKPR ... b alancecenters . ... the Brain Balance Program(R), a revolutionary new approach to help children with Autism, ... For more than ten years, Dr. Robert Melillo , author of ...
... With a Mission of Encouraging Families to Be Incredibly Active ... PARK RIDGE, Ill. April 13 Today, the nation,s egg ... providing 13,500 dyed eggs for the 2009 White ... years, the event brings together families to hunt for and ...
... DocuSyst hosts FileHold document management solution which gives customers the ability ... in software and equipment. , ... Middleton, RI (PRWEB) ... Medicine Inc. is an out patient physical therapy group that provides ...
... Priorities to Improve Health Outcomes and Reduce WasteST. LOUIS ... ESRX ), and WellPoint, Inc. (NYSE: ... a definitive agreement under which Express Scripts, one of ... America, will acquire WellPoint,s NextRx subsidiaries for $4.675 billion, ...
Cached Medicine News:Health News:Chinese Colorectal Cancer Drug Market Will More Than Double by 2012 2Health News:Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win 2Health News:Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win 3Health News:Brain Balance(TM) Centers Picks Adam Kluger Public Relations (AKPR) to Help Promote New Book and Atlanta Event to Raise Awareness About Revolutionary New Way to Treat Learning Disorders; Atlantic Recording Artist/Country Music Star Zac Brown and Dr. Rober 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 3Health News:Olympic Physical Therapy Clears Space and Reduces Clutter with Hosted Document Management Solution from DocuSyst 2Health News:Olympic Physical Therapy Clears Space and Reduces Clutter with Hosted Document Management Solution from DocuSyst 3Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 2Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 3Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 4Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 5Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 6Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 7Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 8
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
(Date:5/22/2013)... , May 22, 2013  The Leukemia & ... million to Valor Biotherapeutics, LLC, a joint venture between ... development, manufacturing, and a Phase I clinical trial for ... outcomes faced by many patients with indolent lymphomas who ... Valor,s protein, IGN002, is a new class ...
(Date:5/22/2013)... May 22, 2013  The Lupus Research Institute (LRI) ... advancing new treatments for lupus nephritis, a serious kidney ... patients. The conference launched a new international alliance of ... Trials Network (LNTN). More than 50 of ... came together to focus on two critical questions: 1) ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
... 2012  Mundipharma International has appointed Paul Medeiros to ... this position, Mr. Medeiros will join the Executive ... extending and expanding avenues for corporate growth within ... are growing faster than any other midsized pharmaceutical ...
... BIOR, OTCQB: BIOR), producer of the FDA cleared STREAMWAY ... it has appointed Joshua Kornberg to the Company,s Board ... Officer of BioDrain, commented, "We are thrilled to bring ... healthcare and biotechnology fund dedicated to bridge financing of ...
Cached Medicine Technology:Mundipharma's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head Its Corporate and Business Development 2BioDrain Medical Inc. Appoints New Board Member 2BioDrain Medical Inc. Appoints New Board Member 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: